Camber Capital Management’s Allergan plc AGN Stock Holding History

Camber Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,000,000	Closed	-$191M	–	36
2019 Q4	$191M	Hold	1,000,000	–	–	9.73%	1
2019 Q3	$168M	Sell	1,000,000 -250,000	-20%	-$40.7M	8.85%	1
2019 Q2	$209M	Sell	1,250,000 -50,000	-4%	-$6.92M	9.76%	2
2019 Q1	$190M	Buy	1,300,000 +300,000	+30%	+$43.5M	9.48%	2
2018 Q4	$134M	Buy	1,000,000 +100,000	+11%	+$16.4M	6.34%	4
2018 Q3	$171M	Sell	900,000 -105,000	-10%	-$19.3M	7.34%	2
2018 Q2	$168M	Buy	1,005,000 +155,000	+18%	+$24.9M	6.45%	2
2018 Q1	$143M	Buy	850,000 +250,000	+42%	+$41.9M	7.02%	3
2017 Q4	$98.1M	Buy	+600,000	New	+$108M	4.8%	5
2017 Q3	–	Sell	-350,000	Closed	-$85.1M	–	36
2017 Q2	$85.1M	Sell	350,000 -85,750	-20%	-$20.1M	4.14%	7
2017 Q1	$104M	Sell	435,750 -107,250	-20%	-$25M	4.22%	6
2016 Q4	$114M	Buy	+543,000	New	+$112M	5.94%	4
2013 Q3	–	Sell	-200,000	Closed	-$25.2M	–	43
2013 Q2	$25.2M	Buy	+200,000	New	+$22.6M	2.6%	15

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Camber Capital Management's AGN Position: Q1 2020 in Review

Camber Capital Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,000,000 shares — an estimated $191M sold.

Camber Capital Management first reported a position in AGN in Q2 2013 and held it in 13 quarters. The position peaked at $209M in Q2 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

Camber Capital Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
Camber Capital Management sold 1,000,000 Allergan plc shares in Q1 2020, an estimated $191M.
Camber Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 13 quarters.
Camber Capital Management's Allergan plc position peaked at $209M in Q2 2019.
876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Camber Capital Management's 13F filing for Q1 2020, filed 15 May 2020.